Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

A bipartisan group of senators are filing a bill that would force health insurers or PBMs to divest their pharmacy businesses ...

Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...

As new research suggests those taking GLP-1 drugs have fewer hospitalisations for alcoholism, a leading specialist warns ...

The childhood obesity epidemic in GCC countries has triggered a debate on the potential use of weight-loss medications such ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

But in a twist this August, a separate part of North Carolina’s government allowed the Medicaid program to start covering the ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?